Skip to content
No results
  • WMDST Portfolio
The World's Most Dangerous Swing Trader
WMDST

The World's Most Dangerous Swing Trader

  • WMDST Portfolio
The World's Most Dangerous Swing Trader
WMDST

The World's Most Dangerous Swing Trader

  • 2026-02-26

Hut 8 Mining Corp. (NASDAQ:HUT) Repositions For Near-Term Upside Driven By AI Deals

Hut 8’s pivot into large-scale AI/data-center leases sharpens revenue visibility even as cash flow remains pressured; technical signals imply a bullish tilt but limited trend strength over the coming weeks.
  • 2026-02-25

AngloGold Ashanti Limited (NYSE:AU) Accelerates Cash Returns Amid Valuation Reset

AngloGold Ashanti projects sustained cash generation while dividend policy shifts to return capital aggressively; balance-sheet strength underpins a fair-valued assessment. Near-term technical momentum suggests upside, but momentum oscillators warn of a short-term consolidation risk.
  • 2026-02-25

Affirm Holdings, Inc (NASDAQ:AFRM) Partnerships Accelerate Reach While Valuation Signals Near-Term Pressure

Affirm shows expanding distribution through major platform deals even as technicals and WMDST valuation indicate constrained upside in the immediate term.
  • 2026-02-25

Suburban Propane Partners, L.P. (NYSE:SPH) Issues Long-Term Notes And Eases Near-Term Refinancing Pressure

Refinancing extends maturities and reduces near-term debt rollover risk while leverage and cash-generation weakness keep upside tethered to improving operating cash flow. Distribution policy and debt service capacity remain the primary fundamentals driving valuation.
  • 2026-02-25

Biglari Holdings Inc. (NYSE:BH) Rebounds Toward Valuation Gap After Insider Buying

Balance-sheet strength and insider purchases contrast with weak short-term momentum, suggesting the next move will depend on whether operational margins improve or technical selling intensifies.
  • 2026-02-25

DoorDash, Inc. (NYSE:DASH) Accelerates Growth While Absorbing Heavy Integration Costs

DoorDash shows accelerating user and order growth as management invests in a unified global platform; near-term margin pressure and elevated multiples create a valuation disconnect with current market pricing.
  • 2026-02-25

Howmet Aerospace Inc. (NYSE:HWM) Accelerates Growth After Strategic Fastener Acquisition

Howmet’s recent deal-making and fresh debt funding push near-term revenue capacity higher while valuation metrics signal elevated investor expectations. Operational cash flow and margin strength underpin expansion but multiple expansion raises near-term price vulnerability.
  • 2026-02-25

Agios Pharmaceuticals, Inc (NASDAQ:AGIO) Accelerates Thalassemia Launch; Near-Term Revenue Upside

Approval-driven commercial rollout and a strong cash base support near-term revenue momentum, while mixed clinical readouts and stretched valuation metrics create measurable execution risk.
  • 2026-02-25

Bwin Interactive Entertainment AG (NASDAQ:BWIN) Signals Immediate Rebound Amid Technical Shift

Momentum indicators show an early bullish inflection while the company’s fundamentals reflect heavy leverage and compressed margins; valuation from WMDST remains under-valued despite stretched multiples. The technical picture suggests a near-term bounce is plausible, but fundamentals limit the scope of sustained upside without operational improvement.

  • 2026-02-24

Travere Therapeutics, Inc (NASDAQ:TVTX) Signals Bullish Rebound As Approval Date Delayed

Commercial traction for FILSPARI and active regulatory news create a catalyst-rich near term; technical signals favor a controlled rebound while valuation metrics remain stretched.
Prev
1 … 5 6 7 8 9 10 11 … 79
Next

Introducing The World’s Most Dangerous Swing Trader

2025-09-04
Prev
1 … 47 48 49 50

Trending now

Comstock Resources, Inc. (NYSE:CRK) Leverages Haynesville Strength; Near-Term Momentum Favors Modest Upside
Bwin Interactive Entertainment AG (NASDAQ:BWIN) Projects Accelerating Recovery Amid Undervalued Fundamentals
Haemonetics Corporation (NYSE:HAE) Advances Cash-Driven Deleveraging While Margins Expand
Corcept Therapeutics Incorporated (NASDAQ:CORT) Endures Regulatory Rebuff; Volatility Likely To Persist